欧洲肿瘤研究与治疗中心宫颈癌患者生活质量问卷（EORTC QLQ-CX 24）研究进展

摘要

EORTC QLQ-CX 24(The Europe Organization for Research and Treatment of Cancer, Quality of Life Questionnaire Cervical Cancer Module，欧洲肿瘤研究与治疗中心宫颈癌患者生活质量问卷)是欧洲癌症研究与治疗组织基于EORTC QLQ-C 30(The Europe Organization for Research and Treatment of Cancer, Quality of Life Questionnaire-Core 30，欧洲肿瘤研究与治疗中癌患者生活质量核心问卷)设计的用于评价宫颈癌患者生活质量的特异性问卷。其可靠性、有效性以及灵敏度已经在欧洲、韩国和东南亚等国家和地区得到了验证，而国内对于该量表的研究仍处于起步阶段。本文将对EORTC QLQ-CX 24的发展和本土化进程进行详细阐述。%EORTC QLQ-CX 24 (The Europe Organization for Research and Treatment of Cancer, Quality of Life Questionnaire Cervical Cancer Module)is the quality of cervical life measured scale, which is based on EORTC QLQ-C 30(The Europe Organization for Research and Treatment of Cancer, Quality of Life Questionnaire-Core 30). The scale has been used in Europe, Korea, Southeast Asia and has been verified to be reliable, efficient and sensitive. The scale for the domestic research is still in its infancy requiring sufficient amount of time applications, validation and clinical trials.